Aeglea Competitors and Similar CompaniesClear all
Aeglea's competitors and similar companies include PHAXIAM Therapeutics.
 Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. | |
Founding Date | Founding Date 2013 | Founding Date 2004 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Austin, US HQ | Locations Lyon, FR HQ Cambridge, US Princeton, US |
Employees | Employees 65117% increase | Employees 49 |
Valuation ($) | Valuation ($) 48.6 m | Valuation ($) 52.8 m |
Financial | ||
Net income | Net income ($155.2m) (FY, 2025) | Net income (€23.5m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
PHAXIAM Therapeutics
HQ
Lyon, FR
Employees
49
PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors.
View company